Eden Research (LON:EDEN) Shares Up 2.6% – Still a Buy?

Eden Research plc (LON:EDENGet Free Report) shares traded up 2.6% on Wednesday . The stock traded as high as GBX 2.78 and last traded at GBX 2.72. 1,402,147 shares traded hands during mid-day trading, an increase of 84% from the average session volume of 760,036 shares. The stock had previously closed at GBX 2.65.

Eden Research Stock Performance

The company has a market cap of £16.53 million, a price-to-earnings ratio of -6.99 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The firm has a fifty day simple moving average of GBX 2.42 and a 200 day simple moving average of GBX 2.88.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.

Further Reading

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.